| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |